Rezultati pretrage - Cheng, Hailing
- Prikaz rezultata 1 – 20 od 28
- Idi na sljedeću stranicu
-
1
-
2
-
3
-
4
H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells od Zhang, Lei, Cheng, Hailing, Yue, Yuxia, Li, Shuangzhan, Zhang, Daping, He, Ruili
Izdano 2018Tekst -
5
miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway od Cao, Qinxue, Wang, Ning, Ren, Lu, Tian, Jun, Yang, Shaoqin, Cheng, Hailing
Izdano 2020Tekst -
6
-
7
-
8
-
9
Melatonin potentiates the cytotoxic effect of Neratinib in HER2(+) breast cancer through promoting endocytosis and lysosomal degradation of HER2 od Liu, Zundong, Sang, Xiaolin, Wang, Min, Liu, Yichao, Liu, Jiao, Wang, Xuefei, Liu, Pixu, Cheng, Hailing
Izdano 2021Tekst -
10
-
11
Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling od Usman, Muhammad Waqas, Gao, Jing, Zheng, Tiezheng, Rui, Chunhua, Li, Ting, Bian, Xing, Cheng, Hailing, Liu, Pixu, Luo, Fuwen
Izdano 2018Tekst -
12
Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling od Usman, Muhammad Waqas, Gao, Jing, Zheng, Tiezheng, Rui, Chunhua, Li, Ting, Bian, Xing, Cheng, Hailing, Liu, Pixu, Luo, Fuwen
Izdano 2019Tekst -
13
PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α od Thorpe, Lauren M., Spangle, Jennifer M., Ohlson, Carolynn E., Cheng, Hailing, Roberts, Thomas M., Cantley, Lewis C., Zhao, Jean J.
Izdano 2017Tekst -
14
-
15
Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer od Wang, Dong, Wang, Min, Jiang, Nan, Zhang, Yuan, Bian, Xing, Wang, Xiaoqing, Roberts, Thomas M., Zhao, Jean J., Liu, Pixu, Cheng, Hailing
Izdano 2016Tekst -
16
A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme: CYP1A1 as a case study od Dai, Zi-Ru, Feng, Lei, Jin, Qiang, Cheng, Hailing, Li, Yan, Ning, Jing, Yu, Yang, Ge, Guang-Bo, Cui, Jing-Nan, Yang, Ling
Izdano 2017Tekst -
17
Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes od Wang, Dong, Li, Chengbo, Zhang, Yuan, Wang, Min, Jiang, Nan, Xiang, Lin, Li, Ting, Roberts, Thomas M., Zhao, Jean J., Cheng, Hailing, Liu, Pixu
Izdano 2016Tekst -
18
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer od Yi, Jingyan, Liu, Chongya, Tao, Zhiwei, Wang, Min, Jia, Yaxun, Sang, Xiaolin, Shen, Lanlin, Xue, Yijue, Jiang, Kui, Luo, Fuwen, Liu, Pixu, Cheng, Hailing
Izdano 2019Tekst -
19
The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis od Utermark, Tamara, Rao, Trisha, Cheng, Hailing, Wang, Qi, Lee, Sang Hyun, Wang, Zhigang C., Iglehart, J. Dirk, Roberts, Thomas M., Muller, William J., Zhao, Jean J.
Izdano 2012Tekst -
20
BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C od Zhang, Yuan, Gao, Xiang, Yi, Jingyan, Sang, Xiaolin, Dai, Zhihong, Tao, Zhiwei, Wang, Min, Shen, Lanlin, Jia, Yaxun, Xie, Daqing, Cheng, Hailing, Liu, Zhiyu, Liu, Pixu
Izdano 2021Tekst